Pro Medicus (OTCMKTS:PMCUF) Stock Price Up 5.1% – Here’s Why

Pro Medicus Limited (OTCMKTS:PMCUF) shares rose 5.1% during trading on Tuesday . The stock traded as high as $136.56 and last traded at $136.56. Approximately 25 shares changed hands during mid-day trading, a decline of 96% from the average daily volume of 617 shares. The stock had previously closed at $129.94.

Analyst Ratings Changes

Separately, Jefferies Financial Group cut Pro Medicus from a “buy” rating to a “hold” rating in a research report on Wednesday, July 8th. One analyst has rated the stock with a Hold rating, According to MarketBeat.com, Pro Medicus presently has a consensus rating of “Hold” and an average target price of $155.00.

Pro Medicus Trading Up 3.2%

The stock’s fifty day moving average price is $125.53 and its 200 day moving average price is $105.82.

Pro Medicus Company Profile

Pro Medicus Limited is an Australia‐based healthcare technology company specializing in advanced medical imaging IT solutions. Its core offerings include radiology information systems (RIS), picture archiving and communication systems (PACS), and enterprise imaging platforms designed to streamline diagnostic workflows and enhance image management for healthcare providers.

The company’s flagship product suite, Visage 7, delivers high-performance visualization and reporting capabilities, enabling radiologists to access and manipulate large datasets with minimal latency.